Dr.ย Kumarย Prabhash
MBBS, MD, DM Medical Oncology
Professor, Medical Oncology
corporate_fareTata Memorial Hospital, Mumbai
Kumar Prabhash
MBBS, MD, DM Medical Oncology
Dr. Kumar Prabhash is a Professor of Medical Oncology at Tata Memorial Hospital, Mumbai, and Head of the Division of Solid Tumour (Adult) at one of India's most respected cancer centres. With over two decades of clinical and research experience, he is widely recognised for his work in lung cancer, head and neck cancer, immunotherapy, and precision oncology.
Dr. Prabhash holds MD and DM Medical Oncology qualifications and is recorded on Tata Memorial Centre's academic faculty list with 21 years of teaching experience. He leads the solid tumour programme at Tata Memorial Hospital, working within a multidisciplinary team that includes surgical oncology, radiation oncology, pathology, radiology, and palliative care. His research profile includes over 100 peer-reviewed publications and involvement in more than 80 projects as principal investigator or co-investigator. He is particularly known for pioneering work on low-dose and ultra-low-dose immunotherapy strategies that aim to make advanced cancer treatment more accessible in low- and middle-income settings. He is also President of the Indian Cooperative Oncology Network (ICON).
CancerFax can coordinate medical-record review, second-opinion requests, and consultation support for international patients seeking care at Tata Memorial Hospital, Mumbai.
Why Consider Dr. Kumar Prabhash?
Dr. Kumar Prabhash combines deep clinical expertise in solid tumour oncology with a strong research record and a recognised commitment to making advanced treatments accessible.
Areas of Specialisation
Advanced solid tumour oncology with a focus on lung cancer, head and neck cancer, and evidence-based systemic therapy
Dr. Kumar Prabhash's clinical practice centres on adult solid tumours, particularly lung cancer and head and neck cancer. His treatment approach integrates chemotherapy, immunotherapy, targeted therapy, and molecular profiling to build individualised treatment plans.
Lung & Thoracic Cancer
Clinical management of non-small cell and other thoracic malignancies through Tata Memorial Centre's dedicated Thoracic Disease Management Group.
- arrow_rightSystemic therapy planning for locally advanced and metastatic NSCLC
- arrow_rightBiomarker-driven selection of targeted agents (EGFR, ALK, ROS1, KRAS)
- arrow_rightImmunotherapy integration with chemotherapy for eligible patients
- arrow_rightTumour board review with surgical, radiation, pathology and pulmonary teams
- arrow_rightStaging work-up coordination and systemic therapy sequencing
Head & Neck Cancer
Evidence-based systemic therapy for recurrent, locally advanced, and metastatic head and neck cancers, including landmark research on affordable immunotherapy.
- arrow_rightChemotherapy and immunotherapy combinations for advanced disease
- arrow_rightLow-dose nivolumab with metronomic chemotherapy โ Phase III research contribution
- arrow_rightMultidisciplinary planning for oral, pharyngeal, and laryngeal cancers
Immunotherapy & Precision Oncology
Research-informed immunotherapy and molecular profiling strategies, including novel low-dose protocols developed to improve treatment access.
- arrow_rightPD-1 and PD-L1 inhibitors including nivolumab for solid tumours
- arrow_rightUltra-low-dose immunotherapy protocols under active investigation
- arrow_rightBiomarker and PD-L1 expression-guided patient selection
- arrow_rightNext-generation sequencing-based treatment planning
- arrow_rightTargeted agents guided by molecular pathology findings
- arrow_rightMetronomic chemotherapy regimens for resource-constrained settings
Procedures & Treatments
Systemic cancer therapy and research-informed treatment planning
Dr. Kumar Prabhash's clinical practice covers the full spectrum of medical oncology for solid tumours, from diagnosis-stage molecular work-up through active systemic treatment and ongoing monitoring.
Systemic Cancer Therapy
Medical OncologyChemotherapy, metronomic regimens, and combination systemic protocols for lung cancer, head and neck cancer, and other solid tumours.
Immunotherapy
Targeted TherapyPD-1 and PD-L1 checkpoint inhibitor therapy, including novel low-dose and ultra-low-dose protocols developed through clinical research.
Molecular Profiling & Diagnosis
DiagnosisBiomarker assessment and molecular diagnostics to guide personalised treatment selection.
Treatment Monitoring & Disease Management
MonitoringOngoing response assessment, toxicity management, and therapy optimisation throughout treatment.
Second Opinion Consultations
Second OpinionIndependent expert review of pathology, treatment history, and molecular profiling for patients seeking a second opinion on their cancer management plan.
Research & Publications
Peer-reviewed contributions in immunotherapy access, lung cancer, and head and neck oncology
Dr. Kumar Prabhash has published over 100 research and review articles in national and international journals and has served as principal investigator or co-investigator on more than 80 projects. His research is particularly noted for advancing affordable immunotherapy strategies relevant to low- and middle-income countries.
Dr. Prabhash received the Max Award for Excellence in Oncology Research for his work on low-dose immunotherapy, recognising contributions that improve treatment access in developing countries.
Education & Training
Dr. Kumar Prabhash holds MD and DM Medical Oncology qualifications. Tata Memorial Centre's official academic faculty record confirms his postgraduate training and lists him as permanent faculty. Specific undergraduate institution details are not publicly confirmed in the sources reviewed.
Clinical Experience
Dr. Kumar Prabhash has spent his entire career at Tata Memorial Hospital, Mumbai, accumulating over two decades of clinical and academic experience in solid tumour oncology. He is currently Professor of Medical Oncology and Head of the Division of Solid Tumour (Adult).
Languages & International
Dr. Kumar Prabhash's consultation languages are not publicly confirmed in the sources reviewed. CancerFax can arrange professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support for international patients consulting at Tata Memorial Hospital.
Language availability not publicly confirmed โ please verify directly. CancerFax coordinates professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Kumar Prabhash
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Kumar Prabhash's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Kumar Prabhash's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Kumar Prabhash before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Kumar Prabhash's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Kumar Prabhash's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Kumar Prabhash's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Kumar Prabhash
Dr. Kumar Prabhash is a Professor of Medical Oncology at Tata Memorial Hospital, Mumbai, and Head of the Division of Solid Tumour (Adult) at Tata Memorial Centre. He holds MD and DM Medical Oncology qualifications and has over 21 years of clinical and teaching experience in solid tumour oncology.
Dr. Prabhash specialises in lung cancer (including non-small cell lung cancer), head and neck cancers, and adult solid tumours. He is a member of Tata Memorial Centre's Thoracic Disease Management Group and has conducted significant research in recurrent or metastatic head and neck squamous cell carcinoma.
Dr. Prabhash's verified treatment areas include chemotherapy, immunotherapy (including low-dose and ultra-low-dose PD-1 inhibitor protocols), targeted therapy, metronomic chemotherapy, molecular profiling-guided treatment planning, and clinical trial-based cancer care. He is particularly known for his research into making immunotherapy affordable for patients in low- and middle-income countries.
CancerFax can coordinate medical-record review and consultation support for international patients seeking an opinion from Dr. Kumar Prabhash at Tata Memorial Hospital, Mumbai, subject to hospital availability and case acceptance. Please submit your reports through CancerFax to begin the process.
Submit your medical reports through CancerFax using the Send Your Reports button. The CancerFax team will review your documents, prepare a structured case summary, and coordinate the next steps with Tata Memorial Hospital, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, molecular profiling results, and treatment history. Dr. Prabhash's expertise in lung cancer, head and neck cancer, and precision oncology makes him a strong choice for patients seeking an independent expert review. The consultation format and availability depend on Tata Memorial Hospital's scheduling.
Connect with Kumar Prabhash Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.